Support more patients. Observe more doses. Deliver better outcomes.
Support and engage patients throughout complex treatment regimens with SureAdhere.
Patient-Centered Tools for Better Public Health Outcomes
Tuberculosis, HIV, and hepatitis C demand long, complex regimens, and keeping patients on track is one of public health's hardest challenges. Missed doses drive drug resistance, treatment failure, and transmission.
SureAdhere meets patients where they are, replacing in-person clinic visits with flexible, remote adherence support across TB, HIV, ART, and hepatitis C programs, without sacrificing outcomes.
Built for complex public health programs.
Enable Offline Treatment Access
Keep every patient in treatment, regardless of location or connectivity, with an app built for all backgrounds and skill levels.
- Offline-capable mobile app for low-connectivity settings
- Icon-driven interface for low-literacy users
- Multilingual support for diverse patient populations
- Works on both iOS and Android devices
Support Complex Regimens
Complete treatment records, real-time messaging, and virtual support deliver care wherever patients are.
- CDC-validated Video Directly Observed Therapy (VDOT)
- Configurable dose reminders and regimen scheduling
- Secure in-app messaging and live virtual visits
- Side-effect capture and symptom reporting
Scale Program Capacity
Reach more patients, observe more doses, and cut admin costs, freeing staff time for high-need cases.
- Real-time adherence dashboards for care coordinators
- Automated reporting to reduce manual data entry
- Works across TB, HIV, PrEP, and Hepatitis C programs
- HIPAA and GDPR compliant with SOC 2 certification
Leading in Privacy & Security
SureAdhere complies with HIPAA and GDPR and is SOC 2 certified, protecting patient data across every program. Our global team backs it with service level agreements in your time zone.
Health departments who trust SureAdhere.
5 California Health Districts: VDOT cuts TB treatment costs by a third.
Five California county health departments, including San Francisco DPH, adopted SureAdhere's video DOT platform to monitor TB treatment across geographically dispersed patients. A multi-site implementation study (Garfein et al., Emerg Infect Dis 2018) found VDOT delivered substantially higher adherence than in-person DOT, at a fraction of the cost, while patients overwhelmingly preferred it.
"VDOT was feasible, acceptable, and resulted in high adherence to TB therapy while saving staff time and reducing costs to health departments."
One platform, many programs.
SureAdhere's proven adherence technology adapts across infectious disease programs, from TB to HIV, PrEP, and hepatitis C.
Tuberculosis (TB)
CDC-validated Video Directly Observed Therapy (VDOT) matches in-person DOT outcomes, letting patients dose from home while providers keep the oversight that drives completion.
HIV Treatment & Prevention
SureAdhere supports both people living with HIV and those on PrEP, making treatment and prevention simpler. Video DOT and real-time tracking keep patients consistent without costly in-person visits.
Hepatitis C
SureAdhere keeps Hepatitis C patients on their daily routine. With treatment now as short as three months and a 95% success rate, patients stay on track while providers monitor adherence effortlessly.
Proven Effective for TB Treatment
Tuberculosis (TB) continues to be one of the most challenging infectious diseases affecting over 10 million lives each year globally.
SureAdhere revolutionizes TB care by making the gold standard of treatment, Directly Observed Therapy (DOT), accessible and affordable for all. Our CDC-validated platform delivers equivalent treatment outcomes to in-person DOT while reducing the burden on patients and providers.
A landmark CDC-led study, published in JAMA Network Open, demonstrated that SureAdhere's video directly observed therapy (VDOT) is as effective as in-person DOT. These findings have shaped global TB treatment guidelines, including recommendations from the WHO and CDC, leading US health departments to adopt VDOT as the standard of care.
View all publicationsThe transition to VDOT has saved us valuable time and resources. Our patients love the freedom it gives them to take their medications on their own schedule.
SureAdhere has increased patient satisfaction, is easy to use, and securely documents patient doses.
SureAdhere has reduced the time we spend on the road for DOT. We can now ensure adherence while monitoring patient needs and providing support.
Ready to strengthen your public health program?
Join 350+ programs already using SureAdhere to reach more patients, improve adherence, and deliver better outcomes at lower cost.